126.00p+6.00 (+5.00%)29 Nov 2021, 16:35
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.

Avacta Group PLC Market & Company News

07:00AVCTFDA Approval of IND Application for AVA6000RNS
18.11.2021 16:41AVCTSecond Price Monitoring ExtnRNS
18.11.2021 16:36AVCTPrice Monitoring ExtensionRNS
02.11.2021 07:00AVCTUpdate on UK Availability of AffiDX TestRNS
14.10.2021 16:36AVCTPrice Monitoring ExtensionRNS
14.10.2021 12:36AVCTIssue of Equity and Total Voting RightsRNS
30.09.2021 07:00AVCTInterim Results for the Period Ended 30 June 2021RNS
29.09.2021 07:00AVCTDevelopment Milestone in LG Chem PartnershipRNS
22.09.2021 16:41AVCTSecond Price Monitoring ExtnRNS
22.09.2021 16:35AVCTPrice Monitoring ExtensionRNS
09.09.2021 07:00AVCTNotice of ResultsRNS
06.09.2021 07:00AVCTNew appointments to Scientific Advisory BoardReach
02.09.2021 07:00AVCTAppointment of Chief Scientific OfficerReach
25.08.2021 16:40AVCTSecond Price Monitoring ExtnRNS
25.08.2021 16:35AVCTPrice Monitoring ExtensionRNS
18.08.2021 07:00AVCTDirectorate ChangeRNS
11.08.2021 07:00AVCTFirst Patient Dosed in AVA6000 Phase 1 TrialRNS
04.08.2021 07:00AVCTUpdate on AffiDX Lateral Flow TestRNS
14.07.2021 07:00AVCTDiagnostics achieves ISO 13485 CertificationRNS
12.07.2021 16:41AVCTSecond Price Monitoring ExtnRNS
12.07.2021 16:35AVCTPrice Monitoring ExtensionRNS
29.06.2021 07:00AVCTAffiDX Lateral Flow Test Detects Delta VariantRNS
28.06.2021 12:13AVCTResult of AGMRNS
21.06.2021 14:05AVCTSecond Price Monitoring ExtnRNS
21.06.2021 14:00AVCTPrice Monitoring ExtensionRNS
21.06.2021 07:00AVCTAffiDX Lateral Flow Test Distribution AgreementRNS
15.06.2021 08:00AVCTIssue of Equity and Total Voting RightsRNS
11.06.2021 14:05AVCTSecond Price Monitoring ExtnRNS
11.06.2021 14:00AVCTPrice Monitoring ExtensionRNS
11.06.2021 11:07AVCTRegistration of AffiDX Lateral Flow Test in EURNS
09.06.2021 09:08AVCTHolding(s) in CompanyRNS
07.06.2021 07:00AVCTMHRA Confirms Registration of Lateral Flow TestRNS
01.06.2021 07:00AVCTUpdate on Lateral Flow Test Regulatory SubmissionsRNS
28.05.2021 07:00AVCTResponse to speculationRNS
25.05.2021 10:00AVCTPosting of Annual Report and Notice of AGMRNS
10.05.2021 10:36AVCTAffiDX SARS-CoV-2 Antigen Lateral Flow Test UpdateRNS
06.05.2021 07:00AVCTChange of Nominated AdviserRNS
30.04.2021 12:37AVCTIssue of EquityRNS
28.04.2021 17:18AVCTIssue of EquityRNS
28.04.2021 16:41AVCTSecond Price Monitoring ExtnRNS
28.04.2021 16:36AVCTPrice Monitoring ExtensionRNS
22.04.2021 07:00AVCTFinal ResultsRNS
20.04.2021 11:05AVCTSecond Price Monitoring ExtnRNS
20.04.2021 11:00AVCTPrice Monitoring ExtensionRNS
20.04.2021 07:00AVCTClinical validation of AffiDX Lateral Flow TestRNS
15.04.2021 16:36AVCTPrice Monitoring ExtensionRNS
13.04.2021 07:00AVCTNotice of Results and Investor PresentationRNS
12.04.2021 13:30AVCTIssue of EquityRNS
06.04.2021 07:00AVCTDistribution Agreement with ABCAM plcRNS
25.03.2021 15:01AVCTDirectorate ChangeRNS
16.03.2021 17:08AVCTIssue of EquityRNS
15.03.2021 17:22AVCTIssue of EquityRNS
09.03.2021 07:00AVCTDiagnostic Licensing Deal with BiokitRNS
08.03.2021 07:00AVCTRapid Antigen Test Detects SARS-CoV-2 VariantsRNS
03.03.2021 17:14AVCTElectronic Communications with ShareholdersReach
24.02.2021 07:00AVCTBusiness UpdateRNS
22.02.2021 07:00AVCTRe: Press SpeculationRNS
18.02.2021 07:00AVCTPhase I CTA for AVA6000 Approved by MHRARNS
16.02.2021 09:05AVCTSecond Price Monitoring ExtnRNS
16.02.2021 09:00AVCTPrice Monitoring ExtensionRNS
16.02.2021 07:00AVCTResults of Initial Evaluation of SARS-CoV-2 LFTRNS
08.02.2021 07:00AVCTCommercial Partnership with MologicRNS
02.02.2021 08:30AVCTIssue of EquityRNS
01.02.2021 07:00AVCTAffyXell $7.3 Million Series A FinancingRNS
29.01.2021 11:00AVCTIssue of EquityRNS
28.01.2021 07:00AVCTCollaboration Agreement with BrukerRNS
07.01.2021 07:00AVCTLicense Agreement with POINT Biopharma Inc.RNS
05.01.2021 11:05AVCTSecond Price Monitoring ExtnRNS
05.01.2021 11:00AVCTPrice Monitoring ExtensionRNS
Showing 1 to 69 of 69